Overview
- 17 FDA inspections are on record.
- 8 inspections produced a Form 483.
- The most recent recorded inspection date is 2026-06-08.
At a glance
Inspections
17
Form 483s
8
EIRs
8
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 1 Jun 2026 – 8 Jun 2026 | Human Drugs | 483 | View 483 → |
| 16 Jan 2024 – 19 Jan 2024 | Biologics | Clean | |
| 12 Jul 2021 – 16 Jul 2021 | Human Drugs | 483 | On file |
| 25 Feb 2019 – 8 Mar 2019 | Animal Drugs & Feeds | Clean | |
| 25 Jun 2018 – 28 Jun 2018 | Human Drugs | 483 | View 483 → |
| 11 Apr 2016 – 15 Apr 2016 | Medical Devices & Rad Health | 483 | View 483 → |
| 6 Oct 2014 | Human Drugs | 483 | On file |
| 28 Apr 2014 – 2 May 2014 | Human Drugs | Clean | |
| 12 Nov 2013 – 15 Nov 2013 | Human Drugs | Clean | |
| 15 Aug 2012 | Not recorded | 483 | On file |
| 7 Jul 2010 | Not recorded | 483 | On file |
| 17 Nov 2008 | Not recorded | 483 | On file |
Observations on record
Form 483 observations cited at this site, most recent first.
28 Jun 2018
21 CFR 58.130(e)
Conduct: changes in automated data entries
Cited by Mark J Seaton, Corey K Reno
28 Jun 2018
21 CFR 58.185(a)(9)
Final report: circumstances affecting data qual., integrity
Cited by Mark J Seaton, Corey K Reno
28 Jun 2018
21 CFR 58.33(b)
Study director: all data recorded and verified
Cited by Mark J Seaton, Corey K Reno
28 Jun 2018
21 CFR 58.35(b)(5)
QAU: authorize deviations from protocols or SOPs
Cited by Mark J Seaton, Corey K Reno
Investigators
FDA investigators tied to this site in the record.
Eric S Pittman4 insp.
Chelsea W Lamm2 insp.
Byron Ho2 insp.
Nancy A Bellamy2 insp.
Barbara A Rusin2 insp.
William D Tingley2 insp.
Dina A Tallman1 insp.
Andrea A Branche1 insp.
Mark J Seaton1 insp.
Corey K Reno1 insp.
Natalie A Mickelsen1 insp.
Dawn C Olenjack1 insp.
Joseph R Haynes1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 58.33(f) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 58.130(e) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 58.185(a)(10) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 58.185(a)(9) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 58.33(b) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 58.35(b)(5) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 58.35(b)(6) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 58.41 | Cited across public-safe Form 483 observations | 2x |
Full site report
Get the verbatim findings behind Charles River Laboratories' 8 Form 483s
Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat